Christa Pike, sentenced to death in 2018 for the 1995 murder of 19‑year‑old Colleen Slemmer, was scheduled for execution on March 27, 2024 at the state penitentiary in Nashville. The plan involved two lethal doses of pentobarbital, but medical experts warned the inmate’s small veins and blood condition could cause the drug to enter her arm instead of the bloodstream, potentially sparking severe tissue damage. When the injections were administered, Pike was immediately unconscious and required ventilation in the hospital.
Pike’s lawyers claimed that the IV protocol was flawed, arguing that the needles could have become dislodged and the caustic drug burned her veins, resulting in swollen, blistered arms upon arrival at the hospital. Despite the injuries, she was revived and is now conscious, speaking, and receiving intensive care, though her long‑term prognosis remains uncertain. Her attorneys have called for Governor Bill Lee to commute her sentence to life without parole, citing her age and documented mental health issues.
In response to the incident, Governor Lee suspended the execution of all death row inmates pending a federal investigation into the Tennessee execution protocol. The state’s prison chief, who had overseen the failed procedure, resigned the day after the event. The Tennessee Department of Corrections has pledged to review its execution procedures and will not carry out another execution until the investigation concludes.
Pike’s survival marks the first time an inmate has lived after receiving lethal injections, sparking a renewed debate over the death penalty for young offenders. The case has drawn attention from civil‑rights groups and lawmakers who argue that procedural safeguards and humane execution methods are essential to any capital punishment system. The investigation will likely shape Tennessee’s future stance on executions and may influence national policy on lethal injection protocols.